Ratings by LifeSci Capital (Cory Jubinville)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/29/2025 | Mereo BipPharma Group | MREO | Downgrade | Market Perform (Outperform) |
2.31 (0.31) |
-86.58% | Details | |
| 6/18/2025 | Verve Therapeutics | VERV | Downgrade | Market Perform (Outperform) |
6.27 (11.13) |
77.51% | Details | |
| 10/8/2024 | Liquidia Technologies | LQDA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/14/2024 | CymaBay Therapeutic | CBAY | Downgrade | Market Perform (Outperform) |
32.21 (32.48) |
0.84% | Details |
